These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11289309)

  • 21. Calcineurin: a poorly understood regulator of muscle mass.
    Hudson MB; Price SR
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2173-8. PubMed ID: 23838168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
    Balakumar P; Jagadeesh G
    Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation.
    Matsuda S; Shibasaki F; Takehana K; Mori H; Nishida E; Koyasu S
    EMBO Rep; 2000 Nov; 1(5):428-34. PubMed ID: 11258483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway.
    Chow CW; Rincón M; Cavanagh J; Dickens M; Davis RJ
    Science; 1997 Nov; 278(5343):1638-41. PubMed ID: 9374467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium/calmodulin-dependent protein kinase II downregulates both calcineurin and protein kinase C-mediated pathways for cytokine gene transcription in human T cells.
    Hama N; Paliogianni F; Fessler BJ; Boumpas DT
    J Exp Med; 1995 Mar; 181(3):1217-22. PubMed ID: 7869038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.
    Lim HW; New L; Han J; Molkentin JD
    J Biol Chem; 2001 May; 276(19):15913-9. PubMed ID: 11279073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chapter 2. Calcineurin signaling and the slow oxidative skeletal muscle fiber type.
    Mallinson J; Meissner J; Chang KC
    Int Rev Cell Mol Biol; 2009; 277():67-101. PubMed ID: 19766967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling.
    Bush EW; Hood DB; Papst PJ; Chapo JA; Minobe W; Bristow MR; Olson EN; McKinsey TA
    J Biol Chem; 2006 Nov; 281(44):33487-96. PubMed ID: 16950785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcineurin in human heart hypertrophy.
    Ritter O; Hack S; Schuh K; Röthlein N; Perrot A; Osterziel KJ; Schulte HD; Neyses L
    Circulation; 2002 May; 105(19):2265-9. PubMed ID: 12010908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
    Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
    J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
    Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
    Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-dependent activation of nuclear factor regulated by interleukin 3/adenovirus E4 promoter-binding protein gene expression by calcineurin/nuclear factor of activated T cells and calcium/calmodulin-dependent protein kinase signaling.
    Nishimura Y; Tanaka T
    J Biol Chem; 2001 Jun; 276(23):19921-8. PubMed ID: 11262393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remodeling muscles with calcineurin.
    Olson EN; Williams RS
    Bioessays; 2000 Jun; 22(6):510-9. PubMed ID: 10842305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.